Ghafouri-Fard Soudeh, Shoorei Hamed, Noferesti Leili, Hussen Bashdar Mahmud, Moghadam Mohammad Hossein Behzad, Taheri Mohammad, Rashnoo Fariborz
Department of Medical Genetics, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Department of Anatomical Sciences, Faculty of Medicine, Birjand University of Medical Sciences, Birjand, Iran; Development Unit of Tabriz Valiasr Hospital, Tabriz University of Medical Sciences, Tabriz, Iran.
Pathol Res Pract. 2023 Aug;248:154667. doi: 10.1016/j.prp.2023.154667. Epub 2023 Jul 3.
miRNAs represent appropriate candidates for treatment of several disorders. However, safe and efficient delivery of these small-sized transcripts has been challenging. Nanoparticle-based delivery of miRNAs has been used for treatment of a variety of disorders, particularly cancers as well as ischemic stroke and pulmonary fibrosis. The wide range application of this type of therapy is based on the important roles of miRNAs in the regulation of cell behavior in physiological and pathological conditions. Besides, the ability of miRNAs to inhibit or increase expression of several genes gives them the superiority over mRNA or siRNA-based therapies. Preparation of nanoparticles for miRNA delivery is mainly achieved through using protocols originally developed for drugs or other types of biomolecules. In brief, nanoparticle-based delivery of miRNAs is regarded as a solution for overcoming all challenges in the therapeutic application of miRNAs. Herein, we provide an overview of studies which used nanoparticles as delivery systems for facilitation of miRNAs entry into target cells for the therapeutic purposes. However, our knowledge about miRNA-loaded nanoparticles is limited, and it is expected that numerous therapeutic possibilities will be revealed for miRNA-loaded nanoparticles in future.
微小RNA(miRNAs)是治疗多种疾病的合适候选物。然而,安全有效地递送这些小尺寸转录本一直具有挑战性。基于纳米颗粒的miRNAs递送已被用于治疗多种疾病,特别是癌症以及缺血性中风和肺纤维化。这类疗法的广泛应用基于miRNAs在生理和病理条件下调节细胞行为中的重要作用。此外,miRNAs抑制或增加多个基因表达的能力使其比基于信使核糖核酸(mRNA)或小干扰核糖核酸(siRNA)的疗法更具优势。用于递送miRNAs的纳米颗粒的制备主要通过使用最初为药物或其他类型生物分子开发的方案来实现。简而言之,基于纳米颗粒的miRNAs递送被视为克服miRNAs治疗应用中所有挑战的一种解决方案。在此,我们概述了一些研究,这些研究使用纳米颗粒作为递送系统,以促进miRNAs进入靶细胞用于治疗目的。然而,我们对负载miRNAs的纳米颗粒的了解有限,预计未来将揭示出负载miRNAs的纳米颗粒的众多治疗可能性。